GFAP in early multiple sclerosis: A biomarker for inflammation

Conclusions GFAP seems to be a useful biomarker for highly active acute inflammation in patients with RRMS as well as with CIS.
Source: Neuroscience Letters - Category: Neuroscience Source Type: research